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Kenya: study protocol of a clusterrandomized efficacy trial of the HITSystem
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Abstract
Background: Early infant diagnosis among human immunodeficiency virus (HIV)-exposed infants is a critical
component of prevention of mother-to-child transmission programs. Barriers to early infant diagnosis include poor
uptake, low retention at designated re-testing intervals, delayed test results, passive systems of communication, and
poor linkage to treatment. This study will evaluate the HIV Infant Tracking System (HITSystem), an eHealth
intervention that streamlines communication and accountability between the key early infant diagnosis
stakeholders: HIV+ mothers and their HIV-exposed infants, healthcare providers, and central laboratory personnel. It
is hypothesized that the HITSystem will significantly improve early infant diagnosis retention at 9 and 18 months
postnatal and the timely provision of services.
Methods/design: Using a phased cluster-randomized controlled trial design, we will evaluate the impact of the
HITSystem on eight primary benchmarks in the 18-month long cascade of care for early infant diagnosis. Study sites
are six government hospitals in Kenya matched on geographic region, resource level, and patient volume. Early
infant diagnosis outcomes of mother-infant dyads (n = 120 per site) at intervention hospitals (n = 3) where the
HITSystem is deployed at baseline will be compared to the matched control sites providing standard care. After
allowing for sufficient time for enrollment and 18-month follow-up of dyads, the HITSystem will be deployed at the
control sites in the end of Year 3. Primary outcomes are retention among mother-infant dyads, initiation of
antiretroviral therapy among HIV-infected infants, and the proportion of services delivered within the optimal time
window indicated by national and study guidelines. Satisfaction interviews with participants and providers will
inform intervention improvements. Cost-effectiveness analyses will be conducted to inform the sustainability of the
HITSystem. Hypothesized outcomes include significantly higher retention throughout the 18-month early infant
diagnosis process, significantly more services provided on-time at intervention sites, and a potential savings to the
healthcare system.
Discussion: This study will evaluate the public health impact of the HITSystem to improve critical early infant
diagnosis outcomes in low-resource settings. Cost-effectiveness analyses will inform the feasibility of scale-up in
other settings.
Trial registration: ClinicalTrials.gov: NCT02072603
Keywords: Early infant diagnosis, HIV-exposed infants, Kenya, HITSystem
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Background
While early infant diagnosis (EID) and prompt treatment
of human immunodeficiency virus (HIV)+ infants are
critical components of prevention of mother-to-child
transmission (PMTCT) efforts, EID has received
minimal attention compared to other HIV prevention
and treatment services. The primary objective of EID is
to promptly identify HIV-infected infants to initiate livesaving antiretroviral therapy (ART) as soon as possible
[1, 2]. Beyond facilitating prompt ART initiation, EID
provides critical reassurance to families whose infants
are uninfected and allows implementation of feeding
plans designed to minimize risk of transmission or
optimize survival among those identified as HIV-infected
[3]. Similarly, EID and infant feeding methods inform
postnatal ART prophylaxis recommendations [4].
EID care and management includes an algorithm and
series of interventions known as the “EID cascade of
care”. This cascade includes the following: (1) the offer
and acceptance of EID testing among HIV-exposed infants, (2) accurate specimen collection, transport, and laboratory processing; (3) relay of results to both
healthcare providers and mothers/caregivers; and (4)
linkage to care: OI prophylaxis for all HIV-exposed infants (cotrimoxazole for pneumocystis jiroveci pneumonia) and ART for HIV+ infants [5]. Because HIV
infection cannot be definitively excluded until at least
6 weeks after cessation of breastfeeding, re-testing infants who initially test negative is critical to identify instances of postnatal HIV transmission. Kenyan EID
guidelines call for routine re-testing of HIV-exposed infants at 9 and 18 months postnatal [6].
Although the guidelines provide clear objectives,
challenges at every step in the EID cascade of care
compromise the quality of EID services provided in
Kenya and other low-resource settings [5, 7–9]. Infant
testing often occurs after the recommended 6 weeks
of age (average age of 3.1 months) [8, 10, 11], and
turn-around times for results are typically quite long
(average of 1–3 months) [10]. Retention throughout
the recommended 18-month postnatal period is low
(32–74.7 %) [8, 12] and less than one-third of Kenya’s
HIV-infected infants are initiated on ART [6, 13].
Transportation, documentation, and communication
challenges contribute to lost or delayed samples [5, 7],
and a passive system for mother notification or followup leads to delayed care and missed opportunities to
support retention [14–16]. Limited coordination
between EID stakeholders limits accountability, efficiency, and linkage to treatment [5, 17]. In addition to
these system-level challenges, mothers experience individual barriers that limit their full participation in
the EID process (e.g., lack of: awareness of the existence or importance of EID services, resources for
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transportation, and fear of disclosure of their HIV status) [18, 19].
Our study aims to evaluate the HIV Infant Tracking
System (HITSystem), a web-based tool designed to
address many of the barriers in current EID service
provision in Kenya, with the ultimate goal of maximizing
the quality of EID services. As a system-level intervention,
it was not deemed feasible or acceptable to randomize at
the individual level; therefore, randomization occurred at
the site (hospital) level. Primary outcomes will be measured at the participant (mother-infant dyad) level and aggregated to report outcomes per hospital. The primary
outcomes for efficacy of the HITSystem are retention
through the EID Cascade of Care (measured by eight
unique benchmarks between 0–18 months postnatal,
including ART initiation among HIV-infected infants)
(Table 1) and efficiency of services (turn-around times for
EID services and ability to meet age and time-specific
targets with the HITSystem compared to control sites
where standard of care services are provided). Secondary
outcomes are maternal and infant predictors of retention,
postnatal period(s) at the highest risk for loss to follow-up,
satisfaction among mothers and providers, and infant HIV
infection status over time. Cost-effectiveness analyses will
quantify resources required to implement the HITSystem
versus standard EID services and calculate potential short
and long-term costs averted by this intervention to inform
scale-up and sustainability.

Methods/design
Trial design

This is a 5-year phased cluster-randomized, controlled
trial design to rigorously evaluate the impact of the HITSystem in Kenya. Study sites are six government hospitals in Kenya matched on geographic region, resource
level, and patient volume to produce three-matched
Table 1 HITSystem targets: eight time-sensitive EID
interventions
1.Initiation of OI prophylaxis at 6 weeks
2.Collect dried blood spot (DBS) for PCR test by 6 weeks
3.Receipt of DBS at lab within 10 days of collection
4.Return of PCR results from lab within 2 weeks
5.Notify mother within 2 weeks of the EID provider receiving results
6.Initiate all HIV-infected infants on ART within 4 weeks of notifying the
mother
7.Retest all HIV-uninfected infants at 9 months, initiate ART w/in 4 weeks
if applicablea
8.Retest all HIV-uninfected infants at 18 months, initiate ART w/in
4 weeks if applicablea
a
Re-testing indicated at these time points or 6 weeks after cessation
of breastfeeding
Greater detail regarding the 8 intervention points and the HITSystem process
has been previously published. [21]
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pairs. One hospital in each pair was randomly assigned
to either the intervention (HITSystem) or control group
(standard of care) condition; resulting in three interventions
and three control study sites. We anticipate a 12-month
window to complete enrollment of n = 120 mother-infant
dyads per hospital, followed by an 18-month follow-up
period (until end of Year 3). In Year 4 the HITSystem will
cross over to initial control sites whose standard of care
data from the 12 months prior will serve as a comparison
for analyses.
Recruitment, participants, and setting

This study is being conducted at government hospitals
at the provincial, county, and sub-county levels in
Kenya. The study protocol is in compliance with the
Helsinki Declaration and was reviewed and approved by
the Institutional Review Boards at the Kenya Medical
Research Institute (protocol #2726) and the University
of Kansas Medical Center (protocol #13793). Matched
hospitals meet the following selection criteria: government funded; provide PMTCT, EID, and ART services;
have at least one dedicated EID provider; and maintain
medical files for HIV-exposed infants. Matched hospitals
reflect regional differences in HIV prevalence, geography
(e.g., average travel distance to clinic, accessible transportation), and cultural influences (e.g., tribal practices,
religious beliefs).
Participant eligibility and consent

As a system-level intervention, any HIV-infected mother
whose infant is <18 months at the time of initial enrollment in EID and presents for care through the Maternal
and Child Health (MCH) department is eligible to be
enrolled in the HITSystem. Mothers <18 years of age or
who present for care through other departments can
utilize the HITSystem, but their data will be exempted
from analyses. Cell phone ownership is not a requirement for participation. Mothers are informed about the
HITSystem during enrollment by trained research or
clinical staff, and those wanting to participate provide
written informed consent prior to enrollment or completion of the baseline survey. A separate informed consent is conducted prior to the satisfaction interview near
the time of 9-month re-testing. Those who wish to opt
out receive the paper-based standard of care. Based on
our pilot experience, we anticipate >95 % participation.
Standard of care

The current standard of care (SOC) for EID in Kenya
has many well-documented challenges [8, 10, 11, 17];
however, when effectively implemented as designed, the
following should take place: The EID provider should
gather information on relevant maternal and infant clinical
and demographic data at the time of postnatal enrollment
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in EID. These data should be entered in a large paper
registry book (HIV-Exposed Infant Registry), organized by
month of birth. Dried blood spot samples should be
collected at the targeted age of 6 weeks and sent via courier to the central laboratory for processing. The samples
should then be processed at the lab and paper polymerase
chain reaction (PCR) test results returned to the hospital
via courier and then sent to MCH to be added to the
mother-infant file and recorded in the EID registry. If the
infant has an HIV-positive test result, EID staff should
contact the mother via phone to ask her to return to the
clinic where she should be counseled about the HIVpositive result and referred to the Comprehensive Care
Center (CCC) where a first line pediatric ART regimen
should be initiated [6, 20]. If the result of the initial PCR
test is negative, the result should be noted in the paper
registry and the mother should be informed at a subsequent clinic visit and advised to return with the infant for
a re-test at 9 months of age. At 9-months postnatal, all
HIV-exposed infants should receive an antibody test, and
if positive, a confirmatory PCR test should be conducted
using the previously described process for PCR testing. If
the antibody result is negative, the mother should be asked
to return 6 weeks after the cessation of breastfeeding or
when the infant is 18 months old to repeat this process.
Even when implemented as designed, the current SOC for
EID has multiple gaps where mothers often fall out of care,
employ extremely limited prospective tracking to identify
when services are indicated, and rely on a passive system for
communicating test results to mothers. These shortcomings
combined with well-documented challenges involving
delayed or lost samples resulting in long turn-around time
for infant test results combine to produce the observed poor
retention and completion rates [8, 10, 11, 17].

Trial intervention
HIV infant tracking system

The HITSystem was designed to overcome barriers in
providing high quality EID in low-resource settings by
utilizing available technology to facilitate timely communication and accountability between primary stakeholders in the EID process. The primary goals of the
HITSystem are the following: to (a) improve EID
utilization and clinical management of HIV-exposed
infants, (b) facilitate early ART initiation for infants
identified as HIV-infected, and c) improve efficiency in
providing time-sensitive interventions. The HITSystem
is accessed online through a computer, using mobile
broadband connections. Reliance on cellular signals
(readily available and reliable in nearly all areas) rather
than hard wired internet access makes this system feasible even in remote areas. The primary components
include the following: (1) tracking of infants to increase
retention, (2) action alerts to complete time-sensitive
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interventions, (3) real time communication of PCR lab
results to hospitals, and (4) real time communication
with mothers regarding required follow-up care via text
messaging or patient tracing.
The HITSystem tracks the care of infants enrolled in
EID so that those who drop out of care can be easily
identified and targeted for outreach. Using the infant’s
date of birth, the HITSystem configures automated electronic alerts for eight time-sensitive interventions to
optimize care for HIV-exposed infants. The order and
timing of these action alerts have been previously published [21]. PCR test results entered into the online system from the lab become available to hospitals in “real
time” thus eliminating the need for costly and unreliable
couriers to transport paper results. Excessive delays for
laboratory test results are also targeted by triggering
alerts at the laboratory for samples received but not
tested within 10 days. When results are available,
mothers are sent an Short Message Service (SMS) message asking them to come to the hospital at their earliest
convenience. Text messages do not relay sensitive information that could compromise confidentiality. In the
case of indeterminate results, mothers are notified to return with infants to collect another sample. To address
one of the weakest areas of current EID care, the HITSystem proactively texts mothers when re-testing of infants is due at 9 and 18 months of age. Infants enrolled
in the HITSystem are tracked until they are either (a)
conclusively determined HIV negative at 18 months and
discharged from EID, (b) determined to be HIV-infected,
initiated on ART, and linked to pediatric HIV care, or (c)
dead or transfered to another health facility.
HITSystem staffing

At each participating hospital, the EID provider enters
relevant data into the HITSystem during initial enrollment and subsequent visits. EID providers at each hospital monitor and respond to the action alerts for
enrolled infants and coordinate participant tracing for
those mothers without phones. This process is supported by a Research Coordinator at each intervention
site. At laboratories, one to two technicians are trained
on the HITSystem and serve as a liaison for follow-up
requests made by EID staff or the Research Coordinator.
The Study Manager reviews action alerts to identify systematic challenges across hospitals, provide quality assurance with data collection, and provide refresher
training with hospital and lab-based staff every 6 months
or earlier as needs arise due to program modifications or
personnel changes. Once deployed, the HITSystem will
continue in the setting until the end of the study. A
phase-out plan will be implemented to maximize adoption among site staff and sustained use after the study
period.
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Training at study sites
Control sites (standard of care)

There is no training or intervention regarding EID procedures at control sites. Nurses directly involved in EID enrollment were trained to assess participant eligibility, to conduct
informed consent, and administer the brief baseline survey.
The same nurses were trained on procedures to ensure participant confidentiality and secure storage of study data.
Intervention sites (HITSystem)

Training for providers began with a discussion of the challenges and barriers to EID care and an introduction to how
the HITSystem is designed to tackle these issues; doing this
was designed to promote buy-in from the facility staff and
generate enthusiasm about the introduction of a new tool.
The intuitive and user-friendly nature of the HITSystem
allows training of key clinic/laboratory personnel in 1 to
2 days. During initial training, new users were educated
about the HITSystem’s standard operating procedures, and
hands-on data entry scenarios were used to tailor training
of each staff member to the specific capacity in which s/he
would utilize the HITSystem. Research team members received extensive HITSystem training to ensure their ability
to respond effectively to any user-challenges and provide
refresher training as needed. Furthermore, they receive ongoing training on study protocols, informed consent, and
data collection and data management procedures to ensure
rigorous conduct of the study protocol.
Participant enrollment

When a mother first presents her infant for EID, the EID
provider creates a new infant record in the EID Registry
notebook (SOC) or the HITSystem (intervention), and data
regarding her antenatal care, maternal ARV prophylaxis regimens, and postpartum infant prophylaxis are entered. The
mother’s cell phone number is also recorded in the HITSystem at this time. The majority of mothers have cell phones
(97 % in urban and 82 % in peri-urban pilot hospitals)
(Finocchario-Kessler et al., Lessons learned from implementing the HIV Infant Tracking System (HITSystem) to
improve early infant diagnosis of HIV outcomes in Kenya,
submitted) [22], but for the few mothers without access or
who prefer not to use their cell phones, we ask for a hand
drawn map from the clinic to their home or major landmark to assist follow-up efforts. At subsequent consultations (PCR test results, 9 month re-testing, etc.), the
infant’s information is updated in the EID Registry notebook (SOC) or pulled up electronically on the HITSystem
and populated with additional data (intervention).
Fidelity assurance procedures

Standard operating procedures were developed for each
step of the study process to standardize training, enrollment, and all data collection procedures. Because it is
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web-based, the intervention features remain uniform
across all sites utilizing the HITSystem. Furthermore,
any modification or corrections to the HITSystem are
instantly applied across all users. HITSystem entries are
routinely reviewed to ensure completeness and appropriate
utilization of the comments section. Site Coordinators
make monthly visits to the control sites to cross reference
enrollment records with the EID Registry and to review
informed consent documents and surveys for completeness
and secure storage. A random sub-sample of informed
consents and surveys are reviewed by the Study Manager
for accuracy and completeness at each site.
Randomization

Prior to randomization, 12 hospitals were surveyed to determine the location, patient volume and HIV prevalence
(through review of EID Registry for prior 12 months),
consistency in current EID procedures, and feasibility of
study procedures. Using these data, six sites with the most
comparable characteristics and regional location were
selected. All individuals enrolled in the study at each
hospital comprised the unit or cluster for randomization.
A random number generator program was then used to
randomly assign control and intervention sites within a
given geographical region. Study statistician was blind to
the process of choosing the sites. Similarly, all research
staff was blind to the randomization process.
Study measures and data sources

This system-level intervention is implemented at the site
level, but outcome measures pertain to both the participant and cluster level. Primary data collection efforts
include the following: (1) retrospective data collection of
EID outcomes prior to study implementation, (2)
baseline surveys at the time of enrollment, (3) ongoing
collection of EID outcome data during the study period,
(4) satisfaction surveys with mothers and providers, and
(5) collection of EID-related costs.
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motivation and self-efficacy for completing EID, partner
support, disclosure, distance and cost to the hospital,
income, education, and number of children.
Primary EID outcomes

The HITSystem output provides infant date of birth,
dates of services (sample collection, sample processed
and result posted, notification of mother, treatment initiation or re-testing as applicable, discharge), and outcomes of service (infant test results at each time period,
initiation of ART, reason for discharge). To assess the
standard provision of EID care at control sites, all
infants entered in the HIV-Exposed Infant Registry Book
each month during the enrollment period are reviewed
until the sample size of n = 120 mother-infant dyads is
achieved per control site. Consistent with the strategy
employed and deemed feasible in the pilot study [21],
and used for the retrospective data collection, we cross
reference the following sources: (1) infant medical
records, (2) hospital HIV-Exposed Infant Registry, (3)
Clinical Care Center (CCC) records, and (4) central
laboratory PCR database to permit parallel assessment
of the outcomes collected by the HITSystem. The
following EID outcomes are measured at all sites.
EID retention EID retention will be characterized as
complete or incomplete. Incomplete EID care (loss to
follow-up) is defined as one or more of the following: (1)
DBS not collected, (2) mother not notified of result, (3)
HIV-infected infant not started on ART, (4) HIVuninfected infant not re-tested at 9 months, and 5) HIVuninfected infant not re-tested at 18 months.
Time to ART initiation In addition to calculating the
proportion of HIV-infected infants who are initiated on
ART, we will calculate the number of days between the
date that the mother was notified of her infant’s HIVpositive status and the date the infant was initiated on
ART.

Retrospective data

Research Coordinators conducted a thorough retrospective
record review of the EID Registry at each hospital to document EID outcomes (Table 1) during the 12 months prior
to study implementation. Supporting medical records
(described in the primary EID outcome section below)
were used to complete missing data points in the EID
Registry.
Baseline surveys

A brief, one-time baseline survey was conducted with each
mother at the time of EID enrollment at intervention and
control sites. Surveys collected basic demographic data and
a variety of potential baseline predictors of EID retention,
including the following: EID knowledge, stigma/violence,

Turn-around time of infant test results We will calculate the number of weeks between the date that the
dried blood spot sample was collected and the date that
the result was made available to the hospital. We will
also calculate the time (in weeks) to notifying the
mother of her infant’s test results.
Timely delivery of EID Services For each of the 8 EID
intervention points (Table 1), we will create an Optimal
EID Care Index to measure whether the service was
completed at all (1 point) or never completed (0 point)
and whether it was completed on-time (1 point) or offtime (0 point). For each EID intervention point, each
mother-infant dyad may receive either 0 point (never
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completed), 1 point (off-time completion), or 2 points
(on-time completion). From these data, we will create an
Optimal EID Care Index score for each dyad by
summing across the 8 EID intervention point scores
(range of 0–16 points). Dyads receiving a minimum
score of 0 will have completed none of the 8 EID intervention points. Dyads receiving a maximum score of 16
will have completed all 8 points on-time. Scores between
0 and 16 will reflect some combination of completion
and on-time completion.

Participant satisfaction

A sub-sample of mothers at all intervention and control
sites (n = 30 per site) will complete satisfaction interviews when their infants are between 9 and 18 months
of age. EID providers at each site and laboratory technicians at participating laboratories will also complete
satisfaction interviews after 6–12 months of study
implementation. Purposive sampling includes mothers
with both HIV-infected and uninfected infants and those
with and without mobile phones. Semi-structured
surveys will elicit mothers’ experiences with the HITSystem and standard EID care. Satisfaction among EID
providers and laboratory technicians will be assessed to
identify perceived strengths and weaknesses, motivations
and confidence to provide EID services, and recommendations to improve future EID outcomes.

Cost-effectiveness

We will evaluate the cost-effectiveness of the HITSystem
from a “donor” or government perspective to evaluate
integration of the HITSystem technology into an existing
EID system. Cost data will be collected three times over
the course of the study: 6, 18, and 30 months after intervention launch. A costing survey documents facility and
laboratory related costs for commodities and services
rendered and estimates low, medium, and high ranges
for each type of expense. Relevant costing data from
mothers is collected by the enrollment survey and again
by the satisfaction surveys.

Reimbursement

As a system-level intervention, all HIV-infected mothers
and their HIV-exposed infants (mother-infant pairs) are
eligible to participate. No remuneration is provided for
enrollment in the HITSystem or completion of enrollment and satisfaction surveys. Satisfaction surveys are
coordinated to coincide with scheduled appointments to
avoid any additional transport burdens. Record review
for cost-effectiveness analyses is conducted by study staff
and thus do not require remuneration.

Page 6 of 8

Statistical analyses

We will calculate descriptive statistics to compare outcomes for each of the eight time-sensitive EID outcomes
by intervention or control hospitals. In our preliminary
analyses, we will estimate general linear models to determine whether there are pre-intervention differences
across conditions and hospitals—for any of the measures
we will be using as predictors or outcomes. Any significantly different variables will be included as covariates in
our analytic models. Given attrition (not completing all 8
EID intervention points) is a major outcome of interest,
we will predict and describe it. Hence, even “missing” or
“lost” dyads will be included in outcome measures.
To predict patterns of EID utilization among HIV-exposed infants, we will first identify bivariate correlates of
the main outcome: EID retention. Correlations between
incomplete EID retention and possible predictors (e.g.,
infant sex, maternal disclosure, etc.) will be conducted
and tested for significance using Phi, Point Biserial, or
Spearman Rho statistics depending on the measurement
level of each predictor. We will then include variables
that are significantly correlated with EID retention in
the generalized linear mixed model and use a stepwise
approach to identify a parsimonious list of predictors,
controlling for the correlation of observations within
cluster with random effects. We will follow the same steps
to assess correlates of the 5 unique EID intervention
points that comprise the summative incomplete EID retention variable:(1) DBS not collected, (2) mother not
notified of result, (3) HIV+ infant not started on ART, (4)
HIV infant not re-tested at 9 months, and (5) HIV infant
not re-tested at 18 months. To identify the most vulnerable time periods for EID retention, we will use survival
analysis with random effects [23] to determine how long
infants stay in EID care and identify time periods when
significant drops in EID retention occur. Visual EID retention curves will illustrate differences in EID care retention
at various time points throughout the 18-month EID
period. Comparisons between intervention and control
participants will highlight the impact of the HITSystem at
various time points in EID utilization.
To assess the impact of the HITSystem on timely administration of eight critical EID interventions (Optimal
EID Care Index), we will analyze data using multilevel
modeling (Proc MIXED in the SAS System version 9.4)
[24] to account for the nesting of time within dyad within
hospital. This will increase the precision of treatment
effect estimates by more correctly estimating standard
errors (that are not correctly estimated when nesting is
ignored) and indicate inferences about change over time
by condition. We will include covariates that may be
associated with EID completion (e.g., infant sex, distance
from hospital, cell phone ownership) in addition to any
pre-intervention differences identified across conditions

Finocchario-Kessler et al. Implementation Science (2015) 10:96

and hospitals. Outcome variables of interest include an aggregate score and sub-scale scores (based on the Optimal
EID Care Index), infant age at first PCR test, proportion
re-tested by 9 months, and proportion re-tested by
18 months.
Power and sample size

To be conservative, the sample size calculation for the
analyses to determine intervention efficacy for retention
and ART initiation is based on the smallest effect size
obtained in our pilot work, 0.44 (range 0.44–1.98). Using
Murray’s method to conduct power analysis for grouprandomized trials, we accounted for the number of
groups, participants in each group, and intraclass correction
(ICC) estimated at 0.05 [25]. This calculation required n =
120 mother-infants dyads from each of the six participant
hospitals for a total of 720 infants (360 from intervention
hospitals and 360 from control hospitals). A sample of 720
infants is sufficient to detect with 80 % power, an effect size
of 0.44 with an ICC range from 0.01 to 0.05. Due to
multiple planned comparisons, a more conservative alpha
level of 0.01 will adjust for possible inflated type I error.
Given the EID volume and low refusal rates anticipated
(<1 % in the pilot study), the required sample size for each
hospital should be met within 12 months of enrollment.
Qualitative analyses

Qualitative satisfaction data will be translated and transcribed prior to content analyses to identify emergent
themes from each stakeholder group. Data will be analyzed
utilizing a web-based program called Dedoose, and themes
will be discussed and confirmed by study staff members to
reach consensus. We will use standard procedures for estimation of the cost of intervention [26] that adhere to the
Panel on Cost-Effectiveness in Health and Medicine’s
guidelines, prior to removing the cost saved from the intervention (e.g., cost of medical care that would have been
spent on HIV-infected infants who were not directly linked
to ART due to the intervention). We will also calculate the
laboratory costs saved by avoiding unnecessary PCR tests
as a result of improved intervention communication, record keeping, and patient retention.
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multiple stakeholders (health facilities, mother-infant
pairs, and laboratories) with an interactive tool that facilitates multidirectional communication, data management, and outcomes monitoring.
The web-based nature of the system minimizes the impact of geographical challenges to the current system, and
this intervention relies heavily on the current communications infrastructures, reducing the need for costly hardware
and system upgrades. This study will allow an analysis of
outcomes at each step of the EID cascade of care and will
facilitate identification of specific challenges within the participating facilities. Previous studies related to system-level
interventions addressing EID have been limited to observational or quasi-experimental studies in which historical data
served as the basis for comparison. The rigor of this study,
as a RCT, greatly increases the value of the comparative
data and will facilitate identification of improvements related to the intervention versus those resulting from the
maturation of EID practices over time.
The intervention is applicable to all HIV-exposed infants and their mothers/guardians, given its adaptability
regardless of cell phone ownership or literacy. However,
it is only able to address outcomes in those mothers
who present themselves for care at facilities. The intervention targets quality of care for clinic-based populations, and the study makes no attempt to directly target
EID uptake. Although the study focuses on a systemlevel intervention, the HITSystem’s ability to capture
and analyze individual factors that may influence EID
retention will form the basis for exploration in further
studies. Given the rapid pace of technological innovation
in Kenya, the clean study design may be challenged by
the introduction of other eHealth interventions at study
sites that may influence existing processes for care. Every
effort will be made to control for external influences in
the design and analyses.
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Trial status

We are approaching the end of study Year 2 and are
actively enrolling participants and collecting data. No
analyses have been conducted at this time.

Discussion
While previous efforts have been made to improve EID
through the utilization of various interventions targeting
only one of the key players in the EID system (most
often the hospital or laboratory) [11, 16, 27–30], the
HITSystem is the first system to comprehensively link
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